CELH
Celsius Holdings, Inc.
CELH has the edge over RYZ overall, supported by stronger fundamentals and stronger valuation.
RYZ
Ryerson Holding Corporation
RYZ's outlook is improving, though it still trails on the overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
RYZ Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Under pressure | |
| Strong |
RYZ's revenue and balance sheet are currently strong, and its profitability is stable, but its cash flow is under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
RYZ PE Valuation
RYZ has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
RYZ Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for RYZ, with profitability improving.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over RYZ on earnings quality, reporting a profit while its opponent remains loss making.
RYZ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | — |
| Q3 2026 | -$0.17 | +$0.54 |
| Q2 2026 | -$1.24 | -$0.79 |
| Q1 2026 | -$1.48 | -$1.26 |
| Q4 2025 | -$1.76 | -$1.50 |
| Q3 2025 | -$0.71 | -211% |
| Q2 2025 | -$0.45 | -124% |
| Q1 2025 | -$0.22 | -108% |
| Q4 2024 | -$0.26 | -106% |
RYZ lost $0.17 per share over the past year, a smaller loss than the year before.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over RYZ on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over RYZ on profitability, with a higher operating margin.
RYZ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +87% |
| Q2 2026 | $2B | +72% |
| Q1 2026 | $1.6B | +38% |
| Q4 2025 | $1.1B | +9.7% |
| Q3 2025 | $1.2B | +3.1% |
| Q2 2025 | $1.2B | -4.6% |
| Q1 2025 | $1.1B | -8.4% |
| Q4 2024 | $1B | -9.4% |
RYZ's revenue has grown year over year for five quarters in a row: $2.2B last quarter, up 87% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.4% | +2.4 points |
| Q2 2026 | 1.7% | +1.2 points |
| Q1 2026 | 1.5% | +1.3 points |
| Q4 2025 | -3.4% | -3.7 points |
| Q3 2025 | -0.1% | -0.6 points |
| Q2 2025 | 0.5% | -1.4 points |
| Q1 2025 | 0.2% | +0.1 points |
| Q4 2024 | 0.3% | -3.7 points |
RYZ's operating margin was 2.4% last quarter, up 2.4 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over RYZ on cash generation, producing positive trailing cash flow while its opponent burns cash.
RYZ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$39.5M | -$18.4M |
| Q2 2026 | $5.1M | -63% |
| Q1 2026 | -$191.4M | -$142.2M |
| Q4 2025 | $91.9M | +34% |
| Q3 2025 | -$21.1M | -120% |
| Q2 2025 | $13.9M | +334% |
| Q1 2025 | -$49.2M | +$20.4M |
| Q4 2024 | $68.7M | +6.2% |
RYZ's free cash flow was −$134M over the past year, against $12M the year before.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over RYZ on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
RYZ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +96K shares |
| 1 year | +63% | +20.3M shares |
| 3 years | +49% | +17.2M shares |
| 5 years | +36% | +14M shares |
| Available history | +39% | +14.7M shares |
RYZ has 53M diluted shares, up 63% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.8M |
| Q2 2026 | $800,000 |
| Q1 2026 | $1.6M |
| Q4 2024 | — |
| Q3 2024 | $36M |
| Q2 2024 | $14M |
| Q1 2024 | $1M |
| Q4 2023 | $6.3M |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
RYZ Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | -0.5x | Net Cash |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
RYZ has the edge over CELH on leverage, with a lower net debt burden relative to earnings.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
RYZ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 66.8 | Neutral |
RYZ's weekly RSI is 57 (neutral) and its Stochastic is 67 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
RYZ PE vs Consumer Defensive Sector
| Metric | RYZ | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
RYZ has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
RYZ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.5 | 9.7% above |
| 20 week MA | $27.1 | 11% above |
| 50 week MA | $26.6 | 14% above |
| 100 week MA | $24.2 | 25% above |
| 200 week MA | $27.1 | 11% above |
RYZ has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
RYZ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.8 | $12.3 | +4.7% |
| 2021 | $12.3 | $24.9 | +102% |
| 2022 | $24.9 | $30.4 | +22% |
| 2023 | $30.4 | $34.7 | +14% |
| 2024 | $34.7 | $18.6 | -46% |
| 2025 | $18.6 | $26.3 | +42% |
| 2026 YTD | $26.3 | $30.2 | +15% |
RYZ has the edge over CELH on returns for 2026, with the stronger performance.